CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Nalox-1 Pharmaceuticals, LLC et al. vs. Opiant Pharmaceuticals, Inc.

Explore the PTAB proceeding IPR2019-00695 filed by Nalox-1 Pharmaceuticals, LLC et al. on 2019-02-19. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2019-00695

Filing Date

2019-02-19

Accorded Filing Date

2019-02-19

Institution Decision Date

2019-10-01

Last Modified Date

β€”

Proceeding Type

IPR

Termination Date

β€”

Trial Status

Institution Denied

Parties & Counsel

Patent Owner / Respondent

Patent Information

1 Patent Involved
Respondent Application Number 15335145
Respondent Patent Number 9629965
Legal Expiration Date
2036-10-26 Active (9.9 yrs remaining)
Injunction Viability (35 U.S.C. Β§ 283) Active Threat
Respondent Inventor Roger CRYSTAL et al
Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Tribunal & APJ Panel Intelligence

Board Intelligence

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Decisions Rendered

0 Total

Proceeding Status

Institution Denied

Administrative Patent Judges (APJ Panel)

Panel assignment tracked upon institution decision entry

Address and Attorney/Agent Information

6 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name Global Patent Group, LLC - LLT-OPIANT - Global Patent Group Inc.
Customer Number 119175
Address 11625 Compton Trl., Fort Worth, TX, 76244, UNITED STATES

Attorney / Agent Information

Reg # Name Phone
34547 Dennis Bennett +1 314-812-8018
36691 Lauren Stevens +1 224-500-9023
59735 Cynthia Hathaway +1 877-812-8020
65040 Brock Levin +1 913-787-3513
70629 Robert Eisler +1 805-223-0028
72123 Stephanie Greer +1 214-803-1130

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 6 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials 5 proceedings
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (6): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (5 found):
PTAB: 5
USPTO PTAB Trial 2019-02-19
IPR2019-00696

Nalox-1 Pharmaceuticals, LLC et al. v. Opiant Pharmaceuticals, Inc.

Asserted Patent
Status: Institution Denied
USPTO PTAB Trial 2019-02-19
IPR2019-00694

Nalox-1 Pharmaceuticals, LLC et al. v. Opiant Pharmaceuticals, Inc.

Asserted Patent
Status: Final Written Decision
USPTO PTAB Trial 2019-02-19
IPR2019-00686

Nalox-1 Pharmaceuticals, LLC et al. v. Opiant Pharmaceuticals, Inc.

U.S. Continuation Sibling (9211253)
Status: Institution Denied
USPTO PTAB Trial 2019-02-19
IPR2019-00687

Nalox-1 Pharmaceuticals, LLC et al. v. Opiant Pharmaceuticals, Inc.

U.S. Continuation Sibling (9211253)
Status: Institution Denied
USPTO PTAB Trial 2019-02-19
IPR2019-00685

Nalox-1 Pharmaceuticals, LLC et al. v. Opiant Pharmaceuticals, Inc.

U.S. Continuation Sibling (9211253)
Status: Final Written Decision
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Proceeding Documents

115
13

JOINT NOTICE OF STIPULATION REGARDING SCHEDULING Paper

2020-03-06 FILING PARTY: PETITIONER
12

Notice of Refund Paper

2019-10-21 FILING PARTY: BOARD
11

PETITIONER NALOX-1 PHARMACEUTICALS, LLCΒΏΒΏΒΏS REQUEST FOR REFUND OF POST-INSTITUTION FEES Paper

2019-10-03 FILING PARTY: PETITIONER
10

Trial Instituted Document Paper

2019-10-01 FILING PARTY: BOARD
9

PATENT OWNER'S RESPONSE TO PETITIONER'S NOTICE Paper

2019-08-12 FILING PARTY: PATENT OWN

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc